N-(5-(2-morpholino-4-oxo-3,4-dihydroquinazolin-8-yl)pyridin-2-yl)acylamides as novel multi-PI3K/DNA-PK/P-gp inhibitors for efficient chemosensitization and MDR alleviationMartina Sukupova, Kamil Kuča, Elham Parsimehr et al.|European Journal of Medicinal Chemistry|2025Cited by 0